Mari Carmen Redal Peña

Mari Carmen Redal Peña

Specialty: Nuclear medicine
Specialty: Nuclear Medicine
Hospitals where he/she works:
  • Hospital Quirónsalud Torrevieja
Serving specialties:
  • Nuclear Medicine

He is currently working as a nuclear medicine doctor at the Oncology Platform of the Hospital Quirónsalud Torrevieja. Areas of specialization in interpretation of functional neuroimaging studies: brain perfusion perfusion SPECT studies, infant SPECT in attention disorders and nigrostriatal pathology in movement disorders. Interpretation of hybrid PET-CT studies (18F-FDG and 18F-FCH).

He studied Medicine at the Faculty of Medicine of Valencia. Between 2001 and 2003, he worked as a medical doctor in the "Unión de Mutuas" mutual accident insurance company in Manises. Specialist in Nuclear Medicine by the Clinical Hospital of Valencia in 2007. She has been a vocal member and secretary of the Melanoma Committee for two years in said Hospital. He has completed the doctorate courses and research proficiency in Physical Medicine and Radiology at the Faculty of Medicine of Valencia. He has an active license as Supervisor of Radioactive Installations, taken at the Polytechnic University of Barcelona.

Specialities that it attends:

Nuclear Medicine

Information and medical appointment

(+34) 966 921 313 / (+34) 966 925 761

ACADEMIC TRAINING:

- Licensed in medicine. University of Valencia, in 1997.
- Title of Medical Specialist in Nuclear Medicine, in 2007.
- Member of the Spanish Society of Nuclear Medicine and Valencian Society.

PUBLICATIONS:

- Biospsia selectiva de ganglio centinela en tumores cutáneos no melanoma, Rev Esp Med Nucl. 2006;25 (1):10-4.
- Importancia del estudio gammagráfico óseo en el diagnóstico del síndrome de SAPHO, Rev Esp Med Nucl. 2010;29 (3):127-130.
- Foco pulmonar facticio con 18F-FDG: posible error en la interpretación de la PET-CT, Rev Esp Med Nucl. 2011;30:248-50.
- Planificación radioterápica con un equipo PET-CT. Comunicación Oral (Congreso nacional de Medicina Nuclear, 2008 Valencia).
- Primeros pacientes realizados en nuestro dentro con 18F-FCH. Comunicación Oral 9/03/2012 (Jornadas de la Sociedad Valenciana de Medicina Nuclear).